55 related articles for article (PubMed ID: 38439030)
21. Identification and prevalence of potentially therapeutic targetable variants of major cancer driver genes in ampullary cancer patients in India through deep sequencing.
Mishra SK; Kumari N; Krishnani N; Singh RK; Mohindra S
Cancer Genet; 2021 Nov; 258-259():41-48. PubMed ID: 34455261
[TBL] [Abstract][Full Text] [Related]
22. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
Hu-Lieskovan S; Bhaumik S; Dhodapkar K; Grivel JJB; Gupta S; Hanks BA; Janetzki S; Kleen TO; Koguchi Y; Lund AW; Maccalli C; Mahnke YD; Novosiadly RD; Selvan SR; Sims T; Zhao Y; Maecker HT
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268350
[TBL] [Abstract][Full Text] [Related]
23. Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
Bala P; Singh AK; Kavadipula P; Kotapalli V; Sabarinathan R; Bashyam MD
Oncogene; 2021 Jan; 40(4):863-874. PubMed ID: 33262464
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
Nakamura Y; Taniguchi H; Ikeda M; Bando H; Kato K; Morizane C; Esaki T; Komatsu Y; Kawamoto Y; Takahashi N; Ueno M; Kagawa Y; Nishina T; Kato T; Yamamoto Y; Furuse J; Denda T; Kawakami H; Oki E; Nakajima T; Nishida N; Yamaguchi K; Yasui H; Goto M; Matsuhashi N; Ohtsubo K; Yamazaki K; Tsuji A; Okamoto W; Tsuchihara K; Yamanaka T; Miki I; Sakamoto Y; Ichiki H; Hata M; Yamashita R; Ohtsu A; Odegaard JI; Yoshino T
Nat Med; 2020 Dec; 26(12):1859-1864. PubMed ID: 33020649
[TBL] [Abstract][Full Text] [Related]
25. Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated.
Xue Y; Balci S; Aydin Mericoz C; Taskin OC; Jiang H; Pehlivanoglu B; Muraki T; Memis B; Saka B; Kim GE; Bandopadhyay S; Knight J; El-Rayes BF; Sarmiento J; Reid MD; Erkan M; Basturk O; Adsay V
Cancer; 2020 Nov; 126(21):4788-4799. PubMed ID: 32857459
[TBL] [Abstract][Full Text] [Related]
26. Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types.
Krigsfeld GS; Prince EA; Pratt J; Chizhevsky V; William Ragheb J; Novotny J; Huron D
J Clin Pathol; 2020 Oct; 73(10):656-664. PubMed ID: 32591352
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer.
Lamberti G; Spurr LF; Li Y; Ricciuti B; Recondo G; Umeton R; Nishino M; Sholl LM; Meyerson ML; Cherniack AD; Awad MM
Ann Oncol; 2020 Jun; 31(6):807-814. PubMed ID: 32171752
[TBL] [Abstract][Full Text] [Related]
28. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Pishvaian MJ; Blais EM; Brody JR; Lyons E; DeArbeloa P; Hendifar A; Mikhail S; Chung V; Sahai V; Sohal DPS; Bellakbira S; Thach D; Rahib L; Madhavan S; Matrisian LM; Petricoin EF
Lancet Oncol; 2020 Apr; 21(4):508-518. PubMed ID: 32135080
[TBL] [Abstract][Full Text] [Related]
29. Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas.
Harthimmer MR; Stolborg U; Pfeiffer P; Mortensen MB; Fristrup C; Detlefsen S
J Clin Pathol; 2019 Nov; 72(11):762-770. PubMed ID: 31256008
[TBL] [Abstract][Full Text] [Related]
30. Detection of
Solomon JP; Hechtman JF
Cancer Res; 2019 Jul; 79(13):3163-3168. PubMed ID: 31196931
[TBL] [Abstract][Full Text] [Related]
31. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer.
Sivaram N; McLaughlin PA; Han HV; Petrenko O; Jiang YP; Ballou LM; Pham K; Liu C; van der Velden AW; Lin RZ
J Clin Invest; 2019 May; 129(8):3264-3276. PubMed ID: 31112530
[TBL] [Abstract][Full Text] [Related]
32. Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.
Wong W; Lowery MA; Berger MF; Kemel Y; Taylor B; Zehir A; Srinivasan P; Bandlamudi C; Chou J; Capanu M; Varghese A; Yu KH; Iacobuzio-Donahue CA; Shia J; Klimstra DS; Jarnagin WR; Stadler ZK; O'Reilly EM
Cancer; 2019 May; 125(9):1441-1448. PubMed ID: 30620386
[TBL] [Abstract][Full Text] [Related]
33. Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: a Surveillance, Epidemiology, and End Results (SEER) cohort study.
Ramai D; Ofosu A; Singh J; John F; Reddy M; Adler DG
Minerva Gastroenterol Dietol; 2019 Jun; 65(2):85-90. PubMed ID: 30488680
[TBL] [Abstract][Full Text] [Related]
34. Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.
Nava Rodrigues D; Rescigno P; Liu D; Yuan W; Carreira S; Lambros MB; Seed G; Mateo J; Riisnaes R; Mullane S; Margolis C; Miao D; Miranda S; Dolling D; Clarke M; Bertan C; Crespo M; Boysen G; Ferreira A; Sharp A; Figueiredo I; Keliher D; Aldubayan S; Burke KP; Sumanasuriya S; Fontes MS; Bianchini D; Zafeiriou Z; Teixeira Mendes LS; Mouw K; Schweizer MT; Pritchard CC; Salipante S; Taplin ME; Beltran H; Rubin MA; Cieslik M; Robinson D; Heath E; Schultz N; Armenia J; Abida W; Scher H; Lord C; D'Andrea A; Sawyers CL; Chinnaiyan AM; Alimonti A; Nelson PS; Drake CG; Van Allen EM; de Bono JS
J Clin Invest; 2018 Oct; 128(10):4441-4453. PubMed ID: 30179225
[TBL] [Abstract][Full Text] [Related]
35. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
[TBL] [Abstract][Full Text] [Related]
36. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Pan D; Kobayashi A; Jiang P; Ferrari de Andrade L; Tay RE; Luoma AM; Tsoucas D; Qiu X; Lim K; Rao P; Long HW; Yuan GC; Doench J; Brown M; Liu XS; Wucherpfennig KW
Science; 2018 Feb; 359(6377):770-775. PubMed ID: 29301958
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.
Demirci NS; Erdem GU
Bosn J Basic Med Sci; 2018 Aug; 18(3):268-274. PubMed ID: 29131967
[TBL] [Abstract][Full Text] [Related]
38. OncoKB: A Precision Oncology Knowledge Base.
Chakravarty D; Gao J; Phillips SM; Kundra R; Zhang H; Wang J; Rudolph JE; Yaeger R; Soumerai T; Nissan MH; Chang MT; Chandarlapaty S; Traina TA; Paik PK; Ho AL; Hantash FM; Grupe A; Baxi SS; Callahan MK; Snyder A; Chi P; Danila D; Gounder M; Harding JJ; Hellmann MD; Iyer G; Janjigian Y; Kaley T; Levine DA; Lowery M; Omuro A; Postow MA; Rathkopf D; Shoushtari AN; Shukla N; Voss M; Paraiso E; Zehir A; Berger MF; Taylor BS; Saltz LB; Riely GJ; Ladanyi M; Hyman DM; Baselga J; Sabbatini P; Solit DB; Schultz N
JCO Precis Oncol; 2017 Jul; 2017():. PubMed ID: 28890946
[TBL] [Abstract][Full Text] [Related]
39. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.
Chaisaingmongkol J; Budhu A; Dang H; Rabibhadana S; Pupacdi B; Kwon SM; Forgues M; Pomyen Y; Bhudhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Sricharunrat T; Phornphutkul K; Sangrajrang S; Cam M; He P; Hewitt SM; Ylaya K; Wu X; Andersen JB; Thorgeirsson SS; Waterfall JJ; Zhu YJ; Walling J; Stevenson HS; Edelman D; Meltzer PS; Loffredo CA; Hama N; Shibata T; Wiltrout RH; Harris CC; Mahidol C; Ruchirawat M; Wang XW;
Cancer Cell; 2017 Jul; 32(1):57-70.e3. PubMed ID: 28648284
[TBL] [Abstract][Full Text] [Related]
40. PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions.
Saraggi D; Galuppini F; Remo A; Urso EDL; Bacchin D; Salmaso R; Lanza C; Bao RQ; Fanelli GN; Guzzardo V; Luchini C; Scarpa M; Farinati F; Fassan M; Rugge M
Histopathology; 2017 Sep; 71(3):470-474. PubMed ID: 28502094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
